TCM Group (TCM) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
FY 2025 revenue grew 6.3% to DKK 1,279 million, with Q4 revenue up 10.5% year-over-year to DKK 333 million and organic growth of 5.3%, driven by both B2B and B2C segments and international expansion, especially in Norway.
Adjusted EBIT for FY 2025 reached DKK 98.3 million (margin 7.7%), reflecting operational efficiency and cost management.
Net profit for FY 2025 rose to DKK 77.8 million, up 34.8% from the previous year.
Completed acquisition of the remaining 55% of Celebert ApS for DKK 80 million, strengthening digital and omni-channel capabilities; four retail stores were also acquired for future divestment.
Major investment in a new automated lacquering facility to enhance production efficiency and product quality.
Financial highlights
FY 2025 revenue: DKK 1,279 million (up 6.3%); Q4 revenue: DKK 333 million (up 10.5% YoY), with 5.3% organic growth.
Adjusted EBIT: DKK 98.3 million (margin 7.7%); adjusted EBITA: DKK 110.2 million; Q4 adjusted EBIT: DKK 31 million.
Gross margin improved to 22.7% for FY and 24.3% in Q4.
Net profit: DKK 77.8 million (up from DKK 57.7 million); earnings per share: DKK 7.51.
Free cash flow for FY: DKK 43.9 million; net interest-bearing debt: DKK 416.8 million; leverage ratio: 3.04.
Outlook and guidance
2026 revenue expected between DKK 1.4 billion and DKK 1.5 billion.
Adjusted EBITA for 2026 guided at DKK 120–140 million.
Focus on full integration of Celebert ApS, maximizing new lacquering facility, and ERP roll-out.
Guidance metric changed from EBIT to adjusted EBITA to better reflect underlying profitability.
Moderately positive market development expected, with gradual improvement in consumer confidence.
Latest events from TCM Group
- Q2 revenue up 30% and guidance raised as B2C and AUBO drive growth, despite B2B weakness.TCM
Q2 20249 Jul 2026 - Revenue up 5.3% in Q1 2025, with margin gains, B2C and Norway growth, and cautious outlook.TCM
Q1 20258 Jul 2026 - Revenue up 17.6% with margin gains and strong outlook, but caution amid volatility.TCM
Q1 20262 Jun 2026 - Q3 2024 saw strong B2C-driven growth, margin expansion, and improved earnings guidance.TCM
Q3 202419 Mar 2026 - B2C growth and margin gains drove 11% revenue rise, with positive 2025 outlook.TCM
Q4 20243 Dec 2025 - Q3 revenue up 4.1%, margins improved, Celebat/Celebert acquired, 2025 guidance narrowed.TCM
Q3 202525 Nov 2025 - Q2 revenue up 5.1%, EBIT up 20%, 2025 guidance narrowed amid softer demand and M&A activity.TCM
Q2 202523 Nov 2025